Global Cities Face Water Crisis, US Oncology Market Triples, Tevogen's Long COVID Cure, Alcohol and Dementia Risk, and more...

(0:10): Study Warns of Imminent 'Day Zero Drought' Threats in Major Global Cities(2:06): US Oncology Diagnostics Market to Triple by 2034, Driven by AI and Personalized Medicine(4:49): Tevogen Bio's TVGN 489 T Cell Therapy Offers Hope for Long COVID Treatment(6:38): Study Links Any Alcohol Consumption to Increased Dementia Risk, Debunking Moderate Drinking Myth(8:13): AI-Driven Blood Tests Revolutionize Spinal Injury Prognosis, Offering Cost-Effective, Early PredictionsTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: openPR